Kidney Disease Improving Global Outcomes (KDIGO) has released its 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, which is also being published as a supplement to Kidney International [2024;105(4S):S117-S314]. The guideline was last updated in 2012.
This resource is for health care professionals who provide kidney care, for people with suspected or diagnosed chronic kidney disease (CKD) and their caregivers, and for policymakers and commissioners of CKD services. Its goal is to address relevant questions with actionable recommendations to guide clinical practice based on a formal evidence review and consensus-based practice points.
The new guideline addresses a wide range of topics, including optimal CKD evaluation and classification, kidney disease risk assessment, management of complications, medication management and drug stewardship in CKD, and strategies for delivering patient-centered care across diverse clinical settings. Highlights include guidance updates on the measurement of estimated glomerular filtration rate and albuminuria, utilization of CKD risk prediction equations, and personalized treatment recommendations for kidney and cardiovascular risk reductions tailored to individual patient needs and preferences.
KDIGO is a global nonprofit organization developing and implementing evidence-based clinical practice guidelines in kidney disease.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.